QuorumCivic. Hidden in plain sight Get the app
Bill intelligence

Medicare expands breast cancer screening for 40-year-olds, prioritizes underserved areas

S. 5258 — PREFERRED Screening Act · Filed by Bill Cassidy (R-LA) · 1 cosponsor · Introduced Aug 5, 2026 · Referred to committee

75%
Transparency
Typical bill: 82%
15/100
Hidden-provision risk
Typical bill: 15/100
Medicare Preventive Care Expansion

Your members of Congress

Enter a ZIP to see where your representative and both senators stood on this bill.

Looked up on this device — your ZIP is never stored on our servers.

What it does

This bill creates a new Medicare payment model to reimburse doctors and other healthcare providers for conducting comprehensive breast cancer risk assessments and developing personalized screening plans for Medicare beneficiaries aged 40–74. Providers will evaluate patients using genetic testing (including BRCA and other genes), family history, breast density, and lifestyle factors to assign risk levels and recommend tailored screening frequency and preventive medications. The model will run for 7 years, prioritize providers in high-mortality states and underserved areas, and be evaluated on whether it improves screening adherence, detects cancers earlier, and reduces overall screening costs.

Why we flagged it

The bill's operative mechanism is a new Medicare payment model for breast cancer risk assessment and personalized prevention planning. It is a public health and preventive care initiative, not a deregulation, subsidy carve-out, or commemorative measure.

What the text implies

  • The bill incentivizes genetic testing and multigene panel testing as part of routine risk assessment, which may increase demand for genetic counseling and testing services, benefiting genetic testing companies and laboratories.
  • Preference for providers submitting de-identified variant data to ClinVar may accelerate public genomic database growth, potentially benefiting research institutions and public health surveillance but also creating data-sharing expectations.

The full analysis lists 5 implications of this text.

Who stands to gain

genetic testing laboratories and companies; genetic counseling services; healthcare providers (physicians, nurse practitioners, physician assistants, certified nurse-midwive

Correlative observation from public records — not evidence of coordination or wrongdoing, and not financial advice.
This page is the record as of today. The app tells you when it changes.
Quorum analysis of the full bill text · 119th Congress · public record